Neogenomics, Inc. splits its revenue into 4 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was Client Direct Billing at $518.8 million, 71% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2026
Sep 30, 2026
|
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
FY 2022
Dec 31, 2022
|
FY 2021
Dec 31, 2021
|
FY 2020
Dec 31, 2020
|
FY 2019
Dec 31, 2019
|
FY 2018
Dec 31, 2018
|
FY 2017
Dec 31, 2017
|
FY 2016
Dec 31, 2016
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
788
|
727
|
661
|
592
|
510
|
484
|
444
|
409
|
277
|
—
|
—
|
| Client Direct Billing |
—
|
519
+9.1%
share 71.3%
|
475
+10.9%
share 72.0%
|
429
+53.3%
share 72.5%
|
280
+10.7%
share 54.9%
|
253
+5.0%
share 52.2%
|
241
+13.1%
share 54.1%
|
213
+29.0%
share 52.0%
|
165
+11.6%
share 59.6%
|
148
|
—
|
| Commercial Insurance |
—
|
118
+17.7%
share 16.2%
|
100
+13.4%
share 15.1%
|
88
+20.1%
share 14.9%
|
73
-7.0%
share 14.4%
|
79
+2.9%
share 16.3%
|
77
-7.9%
share 17.2%
|
83
+105.9%
share 20.3%
|
40
+13.8%
share 14.6%
|
35
|
—
|
| Medicare And Other Governmental |
—
|
91
+7.4%
share 12.5%
|
85
+13.8%
share 12.8%
|
74
+13.4%
share 12.6%
|
66
-8.9%
share 12.9%
|
72
+11.2%
share 14.9%
|
65
+0.0%
share 14.6%
|
65
+82.0%
share 15.8%
|
36
+20.6%
share 12.9%
|
29
|
—
|
| Self Pay Services |
—
|
0
-83.3%
share 0.0%
|
1
+94.6%
share 0.1%
|
0
+122.9%
share 0.1%
|
0
-79.7%
share 0.0%
|
1
+62.2%
share 0.2%
|
0
-21.5%
share 0.1%
|
1
-42.8%
share 0.1%
|
1
+161.5%
share 0.4%
|
0
|
—
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Services-Testing Laboratories (SIC 8734)
- Listed as
- NEO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Fort Myers, FL
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1077183
- Former names
- AMERICAN COMMUNICATIONS ENTERPRISES INC (until Feb 5, 2002)
Other Services-Testing Laboratories companies
- UL Solutions Inc. ULS
- 20/20 Biolabs, Inc. AIDX
- Hypha Labs, Inc. FUNI
Source: SEC EDGAR filings. This is company-reported data, not investment advice.